Markers of Renal Complications in Beta Thalassemia Patients with Iron Overload Receiving Chelation Agent Therapy: A Systematic Review.
Pradana Zaky RomadhonAmi Ashariati PrayogoSiprianus Ugroseno Yudho BintoroMochammad ThahaSatriyo Dwi SuryantoroChoirina WindradiBagus Aulia MahdiDwiki NovendriantoKrisnina Nurul WidiyastutiOkla Sekar MartaniEtha Dini WidiasiEsthiningrum Dewi AgustinEmil PrabowoYasjudan Rastrama PutraHarik Firman ThahadianImam Manggalya AdhikaraDwita Dyah AdyariniKartika PrahasantiAditea Etnawati PutriNarazah Mohd YusoffPublished in: Journal of blood medicine (2022)
The renal complication in beta-thalassemia patients with iron overload receiving chelating agent therapy may progress to kidney disease. Early detection using accurate biological markers is a substantial issue that deserves further evaluation to determine prevention and management.